Soluble form of membrane attack complex independently predicts mortality and cardiovascular events in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention

American Heart Journal

Volumn 164, Issue 5, 2012, Pages 786-792

  Lindberg, Soren ^a   Pedersen, Sune H ^a   Mogelvang, Rasmus ^a   Galatius, Soren ^a   Flyvbjerg, Allan ^b,c   Jensen, Jan Skov ^a,d   Bjerre, Mette ^b,c  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT MEMBRANE ATTACK COMPLEX;

ADULT; AGED; ARTICLE; BLOOD LEVEL; FEMALE; FOLLOW UP; HEART FAILURE; HOSPITAL ADMISSION; HUMAN; IMMUNOASSAY; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

ADULT; AGED; BIOLOGICAL MARKERS; COMORBIDITY; COMPLEMENT MEMBRANE ATTACK COMPLEX; DENMARK; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 84868602894     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2012.08.018     Document Type: Article

References (45)

1. M.J. Davies Anatomic features in victims of sudden coronary death. Coronary artery pathology Circulation 85 1 Suppl 1992 I19 I24
2. R. Ross Atherosclerosis - an inflammatory disease N Engl J Med 340 2 1999 115 126
3. M. Bjerre, T.K. Hansen, and A. Flyvbjerg Complement activation and cardiovascular disease Horm Metab Res 40 9 2008 626 634
4. P.F. Langlois, and M.S. Gawryl Detection of the terminal complement complex in patient plasma following acute myocardial infarction Atherosclerosis 70 1-2 1988 95 105
5. D. Mathey, J. Schofer, and H.J. Schafer Early accumulation of the terminal complement-complex in the ischaemic myocardium after reperfusion Eur Heart J 15 3 1994 418 423
6. K. Distelmaier, C. Adlbrecht, and J. Jakowitsch Local complement activation triggers neutrophil recruitment to the site of thrombus formation in acute myocardial infarction Thromb Haemost 102 3 2009 564 572
7. W.K. Lagrand, H.W. Niessen, and G.J. Wolbink C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction Circulation 95 1 1997 97 103
8. J.H. Hill, and P.A. Ward The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats J Exp Med 133 4 1971 885 900
9. M.J. Walport Complement. First of two parts N Engl J Med 344 14 2001 1058 1066
10. M.J. Walport Complement. Second of two parts N Engl J Med 344 15 2001 1140 1144
11. E.R. Podack, and J. Tschopp Membrane attack by complement Mol Immunol 21 7 1984 589 603
12. T.V. Arumugam, I.A. Shiels, and T.M. Woodruff The role of the complement system in ischemia-reperfusion injury Shock 21 5 2004 401 409
13. M. Yasuda, K. Takeuchi, and M. Hiruma The complement system in ischemic heart disease Circulation 81 1 1990 156 163
14. D.J. Clark, M.W. Cleman, and S.E. Pfau Serum complement activation in congestive heart failure Am Heart J 141 4 2001 684 690
15. M.V. Sorensen, S. Pedersen, and R. Mogelvang Plasma high-mobility group box 1 levels predict mortality after ST-segment elevation myocardial infarction JACC Cardiovasc Interv 4 3 2011 281 286
16. P. Gudmundsson, E. Rydberg, and R. Winter Visually estimated left ventricular ejection fraction by echocardiography is closely correlated with formal quantitative methods Int J Cardiol 101 2 2005 209 212
17. M. Madsen, M. Davidsen, and S. Rasmussen The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry J Clin Epidemiol 56 2 2003 124 130
18. S. Haahr-Pedersen, M. Bjerre, and A. Flyvbjerg Level of complement activity predicts cardiac dysfunction after acute myocardial infarction treated with primary percutaneous coronary intervention J Invasive Cardiol 21 1 2009 13 19
19. G. Vervoort, J.M. Klein Gunnewiek, and H.L. Willems Effect of creatinine assay standardization on the performance of Cockcroft-Gault and MDRD formula in predicting GFR Nephrol Dial Transplant 21 10 2006 2998 2999
20. L.G. Mellbin, M. Bjerre, and S. Thiel Complement activation and prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial Diabetes Care 35 4 2012 911 917
21. A. Vakeva, B.P. Morgan, and I. Tikkanen Time course of complement activation and inhibitor expression after ischemic injury of rat myocardium Am J Pathol 144 6 1994 1357 1368
22. C.B. Granger, K.W. Mahaffey, and W.D. Weaver Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial Circulation 108 10 2003 1184 1190
23. K.W. Mahaffey, C.B. Granger, and J.C. Nicolau Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial Circulation 108 10 2003 1176 1183
24. H.M. Hoffmeister, R. Ehlers, and E. Buttcher Comparison of C-reactive protein and terminal complement complex in patients with unstable angina pectoris versus stable angina pectoris Am J Cardiol 89 8 2002 909 912
25. R. Nijmeijer, P.A. Krijnen, and J. Assink C-reactive protein and complement depositions in human infarcted myocardium are more extensive in patients with reinfarction or upon treatment with reperfusion Eur J Clin Invest 34 12 2004 803 810
26. A. Saraste, K. Pulkki, and M. Kallajoki Apoptosis in human acute myocardial infarction Circulation 95 2 1997 320 323
27. A.P. Vakeva, A. Agah, and S.A. Rollins Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy Circulation 97 22 1998 2259 2267
28. M. Meuwissen, A.C. van der Wal, and H.W. Niessen Colocalisation of intraplaque C reactive protein, complement, oxidised low density lipoprotein, and macrophages in stable and unstable angina and acute myocardial infarction J Clin Pathol 59 2 2006 196 201
29. K. Yasojima, C. Schwab, and E.G. McGeer Complement components, but not complement inhibitors, are upregulated in atherosclerotic plaques Arterioscler Thromb Vasc Biol 21 7 2001 1214 1219
30. L.A. Trouw, M. Okroj, and K. Kupreishvili C4b-binding protein is present in affected areas of myocardial infarction during the acute inflammatory phase and covers a larger area than C3 PLoS One 3 8 2008 e2886
31. H. Schafer, D. Mathey, and F. Hugo Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium J Immunol 137 6 1986 1945 1949
32. P.S. Seifert, F. Hugo, and G.K. Hansson Prelesional complement activation in experimental atherosclerosis. Terminal C5b-9 complement deposition coincides with cholesterol accumulation in the aortic intima of hypercholesterolemic rabbits Lab Invest 60 6 1989 747 754
33. B. Ando, T. Wiedmer, and K.K. Hamilton Complement proteins C5b-9 initiate secretion of platelet storage granules without increased binding of fibrinogen or von Willebrand factor to newly expressed cell surface GPIIb-IIIa J Biol Chem 263 24 1988 11907 11914
34. R.D. Lewis, C.L. Jackson, and B.P. Morgan The membrane attack complex of complement drives the progression of atherosclerosis in apolipoprotein E knockout mice Mol Immunol 47 5 2010 1098 1105
35. M.H. Kaplan, and J.E. Volanakis Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingomyelin J Immunol 112 6 1974 2135 2147
36. J. Siegel, R. Rent, and H. Gewurz Interactions of C-reactive protein with the complement system. I. Protamine-induced consumption of complement in acute phase sera J Exp Med 140 3 1974 631 647
37. H.X. Jiang, J.N. Siegel, and H. Gewurz Binding and complement activation by C-reactive protein via the collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q J Immunol 146 7 1991 2324 2330
38. K. Yasojima, C. Schwab, and E.G. McGeer Generation of C-reactive protein and complement components in atherosclerotic plaques Am J Pathol 158 3 2001 1039 1051
39. S. Bhakdi, M. Torzewski, and M. Klouche Complement and atherogenesis: binding of CRP to degraded, nonoxidized LDL enhances complement activation Arterioscler Thromb Vasc Biol 19 10 1999 2348 2354
40. K. Yasojima, C. Schwab, and E.G. McGeer Human heart generates complement proteins that are upregulated and activated after myocardial infarction Circ Res 83 8 1998 860 869
41. P.M. van der Zee, E. Biro, and L.A. Trouw C-reactive protein in myocardial infarction binds to circulating microparticles but is not associated with complement activation Clin Immunol 135 3 2010 490 495
42. H. Tomoda, and N. Aoki Prognostic value of C-reactive protein levels within six hours after the onset of acute myocardial infarction Am Heart J 140 2 2000 324 328
43. I. Abdelmouttaleb, N. Danchin, and C. Ilardo C-reactive protein and coronary artery disease: additional evidence of the implication of an inflammatory process in acute coronary syndromes Am Heart J 137 2 1999 346 351
44. M. Bjerre Novel strategies in ischemic heart disease Inflammatory Biomarkers in Ischemic Heart Disease: Intech 2012
45. M.N. Busche, and G.L. Stahl Role of the complement components C5 and C3a in a mouse model of myocardial ischemia and reperfusion injury Ger Med Sci 8 2010 Sept 8 pii: Doc20